Literature DB >> 31518657

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.

Pouya Saeedi1, Inga Petersohn2, Paraskevi Salpea2, Belma Malanda2, Suvi Karuranga2, Nigel Unwin3, Stephen Colagiuri4, Leonor Guariguata5, Ayesha A Motala6, Katherine Ogurtsova7, Jonathan E Shaw8, Dominic Bright9, Rhys Williams9.   

Abstract

AIMS: To provide global estimates of diabetes prevalence for 2019 and projections for 2030 and 2045.
METHODS: A total of 255 high-quality data sources, published between 1990 and 2018 and representing 138 countries were identified. For countries without high quality in-country data, estimates were extrapolated from similar countries matched by economy, ethnicity, geography and language. Logistic regression was used to generate smoothed age-specific diabetes prevalence estimates (including previously undiagnosed diabetes) in adults aged 20-79 years.
RESULTS: The global diabetes prevalence in 2019 is estimated to be 9.3% (463 million people), rising to 10.2% (578 million) by 2030 and 10.9% (700 million) by 2045. The prevalence is higher in urban (10.8%) than rural (7.2%) areas, and in high-income (10.4%) than low-income countries (4.0%). One in two (50.1%) people living with diabetes do not know that they have diabetes. The global prevalence of impaired glucose tolerance is estimated to be 7.5% (374 million) in 2019 and projected to reach 8.0% (454 million) by 2030 and 8.6% (548 million) by 2045.
CONCLUSIONS: Just under half a billion people are living with diabetes worldwide and the number is projected to increase by 25% in 2030 and 51% in 2045.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Diabetes; Impaired glucose tolerance; International Diabetes Federation; Prevalence; Projections; Undiagnosed

Mesh:

Year:  2019        PMID: 31518657     DOI: 10.1016/j.diabres.2019.107843

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  1470 in total

Review 1.  Targeting Stem Cells in Chronic Inflammatory Diseases.

Authors:  Mari van de Vyver; Carine Smith; Yigael S L Powrie
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  High Dietary Fat Consumption Impairs Axonal Mitochondrial Function In Vivo.

Authors:  Marija Sajic; Amy E Rumora; Anish A Kanhai; Giacomo Dentoni; Sharlini Varatharajah; Caroline Casey; Ryan D R Brown; Fabian Peters; Lucy M Hinder; Masha G Savelieff; Eva L Feldman; Kenneth J Smith
Journal:  J Neurosci       Date:  2021-03-30       Impact factor: 6.167

Review 3.  Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes.

Authors:  Yasaman Ghorbani; Katherine J P Schwenger; Johane P Allard
Journal:  Eur J Nutr       Date:  2021-03-02       Impact factor: 5.614

Review 4.  The effects of helminth infections against type 2 diabetes.

Authors:  Yan-Ru Gao; Rong-Hui Zhang; Ru Li; Chun-Lian Tang; Qun Pan; Peng Pen
Journal:  Parasitol Res       Date:  2021-05-18       Impact factor: 2.289

5.  Opuntia dillenii (Ker Gawl.) Haw., Seeds Oil Antidiabetic Potential Using In Vivo, In Vitro, In Situ, and Ex Vivo Approaches to Reveal Its Underlying Mechanism of Action.

Authors:  Mohamed Bouhrim; Hayat Ouassou; Salima Boutahiri; Nour Elhouda Daoudi; Hamza Mechchate; Bernard Gressier; Bruno Eto; Hamada Imtara; Amal A Alotaibi; Mohammed Al-Zharani; Abderrahim Ziyyat; Hassane Mekhfi; Abdelkhaleq Legssyer; Mohammed Aziz; Mohamed Bnouham
Journal:  Molecules       Date:  2021-03-17       Impact factor: 4.411

6.  Non-diabetic glomerular lesions in diabetic kidney disease: clinical predictors and outcome in an Eastern European cohort.

Authors:  Otilia Popa; Gabriel Stefan; Cristina Capusa; Eugen Mandache; Simona Stancu; Nicoleta Petre; Gabriel Mircescu
Journal:  Int Urol Nephrol       Date:  2020-10-31       Impact factor: 2.370

7.  Anthocyanins regulate serum adipsin and visfatin in patients with prediabetes or newly diagnosed diabetes: a randomized controlled trial.

Authors:  Liping Yang; Yun Qiu; Wenhua Ling; Zhaomin Liu; Lili Yang; Changyi Wang; Xiaolin Peng; Li Wang; Jianying Chen
Journal:  Eur J Nutr       Date:  2020-09-15       Impact factor: 5.614

Review 8.  Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.

Authors:  Radica Z Alicic; Emily J Cox; Joshua J Neumiller; Katherine R Tuttle
Journal:  Nat Rev Nephrol       Date:  2020-11-20       Impact factor: 28.314

Review 9.  Diabetes Risk and Control in Multi-ethnic US Immigrant Populations.

Authors:  Jennifer Dias; Sandra Echeverria; Victoria Mayer; Teresa Janevic
Journal:  Curr Diab Rep       Date:  2020-11-20       Impact factor: 4.810

10.  Foot care knowledge, attitudes and practices among patients with diabetic foot and amputation in St. Kitts and Nevis.

Authors:  Gracelyn Hanley; Piao-Yi Chiou; Chieh-Yu Liu; Hui-Mei Chen; Stefani Pfeiffer
Journal:  Int Wound J       Date:  2020-08-03       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.